Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Quoin Pharmaceuticals Ltd ADR (QNRX)

Quoin Pharmaceuticals Ltd ADR (QNRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,536
  • Shares Outstanding, K 5,050
  • Annual Sales, $ 0 K
  • Annual Income, $ -8,690 K
  • EBIT $ -9 M
  • EBITDA $ -9 M
  • 60-Month Beta 1.75
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.62
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -4.05
  • Most Recent Earnings $-0.47 on 11/07/24
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.44
  • Number of Estimates 1
  • High Estimate -0.44
  • Low Estimate -0.44
  • Prior Year -2.08
  • Growth Rate Est. (year over year) +78.85%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.4250 +64.78%
on 12/20/24
0.8700 -19.51%
on 12/09/24
-0.1187 (-14.49%)
since 12/03/24
3-Month
0.4250 +64.78%
on 12/20/24
1.5700 -55.39%
on 10/16/24
+0.2129 (+43.68%)
since 10/03/24
52-Week
0.4250 +64.78%
on 12/20/24
6.1800 -88.67%
on 03/04/24
-3.9797 (-85.04%)
since 01/03/24

Most Recent Stories

More News
Quoin Pharmaceuticals Announces Pricing of $6.8 Million Public Offering

QNRX : 0.7003 (+4.29%)
Quoin Pharmaceuticals Announces FDA Clearance to Initiate New QRX003 Netherton Syndrome Clinical Study

QNRX : 0.7003 (+4.29%)
Quoin Pharmaceuticals Reports Positive Interim Clinical Data for QRX003 in Netherton Syndrome Studies

Quoin Pharmaceuticals reports positive interim results for QRX003 in Netherton Syndrome studies, showing significant skin improvement without safety concerns.Quiver AI SummaryQuoin Pharmaceuticals Ltd....

QNRX : 0.7003 (+4.29%)
Quoin Pharmaceuticals Announces Positive Interim Data from Two Ongoing Netherton Syndrome Clinical Studies

QNRX : 0.7003 (+4.29%)
Quoin Pharmaceuticals Provides Corporate Update and Announces Third Quarter 2024 Financial Results

QNRX : 0.7003 (+4.29%)
Quoin Pharmaceuticals Initiates Clinical Testing of Lead Product in Pediatric Netherton Syndrome Patient

QNRX : 0.7003 (+4.29%)
Quoin Pharmaceuticals to Announce Third Quarter 2024 Financial Results on Thursday, November 7, 2024

QNRX : 0.7003 (+4.29%)
Quoin Pharmaceuticals Announces Further International Expansion of Ongoing Clinical Trials for Netherton Syndrome

QNRX : 0.7003 (+4.29%)
Asensus Surgical Continues to Spearhead Innovations and Growth in Surgical Robotics

Asensus Surgical Continues to Spearhead Innovations and Growth in Surgical Robotics

QNRX : 0.7003 (+4.29%)
ASXC : 0.3479 (+0.64%)
Asensus Shares First Quarter Results and Future Plans

Asensus Shares First Quarter Results and Future Plans

QNRX : 0.7003 (+4.29%)
ASXC : 0.3479 (+0.64%)

Business Summary

Quoin Pharmaceuticals is a specialty pharmaceutical company focused on rare and orphan diseases. Quoin Pharmaceuticals, formerly known as Cellect Biotechnology Ltd., is based in Tel Aviv.

See More

Key Turning Points

3rd Resistance Point 0.9095
2nd Resistance Point 0.8598
1st Resistance Point 0.7800
Last Price 0.7003
1st Support Level 0.6505
2nd Support Level 0.6008
3rd Support Level 0.5210

See More

52-Week High 6.1800
Fibonacci 61.8% 3.9816
Fibonacci 50% 3.3025
Fibonacci 38.2% 2.6234
Last Price 0.7003
52-Week Low 0.4250

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar